$RLFTF RELIEF POINTS TO APPLIED PHARMA RESEARCH (APR) NEWS

New Post Public Reply Private Reply Replies (0) Message Board
mc67
439
$RLFTF RELIEF POINTS TO APPLIED PHARMA RESEARCH (APR) NEWS RE: PIVOTAL COVID-19 TRIAL INITIATION WITH NOVEL NASAL SPRAY

17 May 2021

Relief Points to Applied Pharma Research (APR) News re: Pivotal COVID-19 Trial Initiation with Novel Nasal Spray

Geneva, Switzerland, May 17, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF)(“Relief”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19-induced lung injury, is pleased to see the recent announcement by APR Applied Pharma Research S.A. ("APR" regarding the initiation of a pivotal clinical trial with its novel nasal spray, temporarily codenamed APR-AOS2020, a Class III medical device, in patients with mild COVID-19.

The trial is designed to evaluate the efficacy and safety of the product in reducing viral load in the upper respiratory airways in recently infected individuals. The APR press release can be found here.

“We are very happy to see the start of this pivotal clinical trial with one of the main product candidates in APR’s portfolio so shortly after we signed the binding term sheet to acquire all shares of this exciting company,” Jack Weinstein, Chief Financial Officer and Treasurer of Relief, said. “We strongly believe that the acquisition of APR will fit perfectly with Relief's strategy to expand our clinical pipeline as it will add synergistic and promising late-stage candidates to treat various indications in rare or debilitating diseases with high unmet medical needs, in addition to marketed products. We are very much looking forward to working with APR and advance our joined product pipeline as quickly as possible to reach patients.”

Relief and APR, a privately held Swiss pharmaceutical company with over 25 years’ experience in identifying, developing and commercializing known molecules engineered with drug delivery systems in niche and rare diseases on a global basis, announced on May 4, 2021 that the companies had signed a binding term sheet for Relief to acquire all outstanding shares of APR. See “Relief and Applied Pharma Research (APR) Sign Binding Term Sheet for Relief to Acquire All Outstanding Shares of APR.” For a period of 60 days, Relief has the exclusive right to negotiate and close the transaction on the basis of the terms and conditions in the signed Term Sheet. With APR’s products already on the market, the acquisition will provide Relief with commercial revenues and provide access to an established commercial organization in key European markets that Relief hopes to leverage for other programs. In addition, Relief will gain a robust clinical portfolio in rare or debilitating diseases with high unmet medical need that is synergistic with Relief’s current development pipeline.

###

ABOUT RELIEF THERAPEUTICS HOLDING AG
Relief focuses primarily on clinical-stage programs based on molecules with a history of clinical testing and use in human patients or a strong scientific rationale. Relief’s lead drug candidate RLF-100TM (aviptadil), a synthetic form of Vasoactive Intestinal Peptide (VIP), is in late-stage clinical testing in the U.S. for the treatment of respiratory deficiency due to COVID-19. As part of its pipeline diversification strategy, in March 2021, Relief entered into a Collaboration and License Agreement with Acer Therapeutics for the worldwide development and commercialization of ACER-001. ACER-001 is a taste-masked and immediate release proprietary powder formulation of sodium phenylbutyrate (NaPB) for the treatment of Urea Cycle Disorders and Maple Syrup Urine Disease.

RELIEF THERAPEUTICS Holding AG is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbol RLFTF.

For more information, visit www.relieftherapeutics.com.

Follow us on LinkedIn.

Contact:
CONTACT:

RELIEF THERAPEUTICS Holding AG:
Jack Weinstein
Chief Financial Officer and Treasurer
contact@relieftherapeutics.com
For media inquiries contact:
MEDIA CONTACT (RELIEF):
MC Services AG
Anne Hennecke
Tel.: +49 (0) 211-529-252-22
relief@mc-services.eu
Investor relations contact:
INVESTOR RELATIONS CONTACT (RELIEF):
MC Services AG
Anne Hennecke
Tel.: +49 (0) 211-529-252-22
relief@mc-services.eu


https://relieftherapeutics.com/newsblog/relie...asal-spray

Mondobiotech Holding AG Basel (RLFTF) Stock Research Links

RLFTF Board Company Profile Buy Rating Time & Sales News Filings Financials
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

1095 Days Finds the Army's Long, Ordinary War Life

Updated Category News Views 125

A cracked barracks window can explain more than a polished battlefield legend. Dean R. Cherry's 1095 Days: Three Years in the Green Machine, newly released by Palmetto Publishing, puts its weight on the parts of Army life that war stories often shove into the background: cold, waiting, paperwork, arbitrary rules, lousy living conditions, and the private mental math of...

Continue Reading
Evotec’s Second IND Adds Proof to Its Glue Platform

Updated Category News Views 73

Two IND acceptances from one long-running alliance is not nothing, especially in a drug-discovery business where plenty of polished platform talk never makes it to the clinic. Evotec has cleared that modest but meaningful bar again with Bristol Myers Squibb: a second molecular-glue candidate has received FDA acceptance for an Investigational New Drug application. The...

Continue Reading
Dimora's MegaSorb Review Sharpens Wound Care Choices

Updated Category News Views 105

Wound care is one of those corners of healthcare where flashy language runs into real-life consequences fast. Dimora Medical’s newly announced collaboration with podiatric physician Dr. Ebonie Vincent-Sleet brings a professional voice to its MegaSorb silicone foam dressing line, specifically a 4×4-inch product reviewed for its intended place in care. That is useful...

Continue Reading
Common Tiger Bets $499 on Better Outdoor Seating Design

Updated Category News Views 59

A chair that refuses to slump into the camping aisle is Common Tiger's whole argument, and frankly it is a smarter argument than another flimsy fold-up contraption pretending comfort is optional. The Los Angeles, female-founded and women-owned brand is launching with one product, The Daymaker, after four years of development. That is a long runway for a debut chair, which...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 167

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 60

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
MegaRobo's Nearly $200 Million Bet on Learning Labs

Updated Category News Views 98

A lab robot that merely follows instructions is old news; a system that learns from the mess it makes is the expensive part. MegaRobo has raised nearly US$200 million to push toward that harder prize: infrastructure that links AI reasoning to actual experiments, instruments, automation and the results that come back. For investors watching AI for Science, this is more...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 112

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
Dar Global’s $700M Qatar Bet Leans on Trump Branding

Updated Category News Views 7

Luxury property launches rarely arrive quietly, and this one came wrapped in Palm Beach ceremony, championship golf and a very loud brand name. Dar Global has formally introduced Trump International Simaisma, Qatar, a QAR 2.5 billion development—about $700 million—alongside The Trump Organization. That is a meaningful chunk of real estate ambition, not a little side...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 5

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading

Top 5 Most Recently Viewed Articles

City Office REIT's 2024 Q3 Performance and Strategic Outlook

Updated Category News Views 266

City Office REIT's Third Quarter 2024 Financial Results Overview City Office REIT, Inc. (NYSE: CIO) has recently released its financial results for the third quarter of 2024. In this quarter's report, the company highlighted a substantial progression in its office real estate fundamentals, showcasing resilience and strategic maneuvers in a competitive market. Key...

Continue Reading
Latest Transactions of Ringkjøbing Landbobank A/S Shares

Updated Category News Views 146

Overview of Share Transactions In the realm of financial regulations, the duty of disclosure plays a crucial role. When it comes to transactions involving shares, companies must adhere to specific guidelines to maintain transparency. Recently, Ringkjøbing Landbobank A/S has reported its share transactions, which is particularly important for stakeholders, regulatory...

Continue Reading
Unlocking Success: The Power of Trust in Business Practices

Updated Category News Views 280

Trust as the Foundation of Business Success Recent insights have emerged showing that trust not only fosters a positive workplace culture but also serves as a significant catalyst for long-term financial prosperity. According to research from Great Place To Work®, companies that prioritize trust within their employee relationships consistently outperform their...

Continue Reading
Investing in Texas Instruments: A 15-Year Journey of Growth

Updated Category News Views 126

The Impressive Growth of Texas Instruments Texas Instruments (NASDAQ: TXN), a leader in semiconductor technology, has demonstrated remarkable performance over the last 15 years. With an annualized return of 15.69%, it has surpassed market averages by 3.27%. This kind of consistent growth illustrates why many investors find TXN appealing. Your $1000 Investment in TXN If an...

Continue Reading
Sarah Schmelzel Joins SERVPRO as New Brand Ambassador

Updated Category News Views 414

Sarah Schmelzel Becomes a SERVPRO Brand Ambassador Gallatin, Tennessee – SERVPRO, a well-regarded leader in cleanup, restoration, and construction, proudly announces the partnership with LPGA golfer Sarah Schmelzel as a brand ambassador for the upcoming season. This collaboration underscores SERVPRO’s deep-rooted involvement with top-tier sports organizations,...

Continue Reading